# Cohort Studio™ for Cardiovascular Services
### Executive Briefing

**Population Health Intelligence for Cardiovascular Risk Management, Quality Improvement, and Value-Based Care**

**Prepared for:** Director, Cardiovascular Services
**Platform:** Cohort Studio™
**Strategic Focus:** Facilitating Value-Based Care Through Population Health Intelligence
**Date:** July 2026

Copyright © 2026 Katherine J. Ombrellaro
*Conceptual platform overview, prepared for strategic discussion. See closing note on scope and validation status.*

---

## Contents

- [Executive Summary](#executive-summary)
- [Strategic Context: Cardiology Under Value-Based Care](#strategic-context-cardiology-under-value-based-care)
- [Cardiovascular Population Intelligence](#cardiovascular-population-intelligence)
- [Cardiology Applications](#cardiology-applications)
- [Cardiology as a Population Health Partner](#cardiology-as-a-population-health-partner)
- [Cross-Specialty Cardiovascular Intelligence](#cross-specialty-cardiovascular-intelligence)
- [Evidence-First Analytics](#evidence-first-analytics)
- [Privacy-Preserving Architecture](#privacy-preserving-architecture)
- [CMS Value-Based Care Alignment](#cms-value-based-care-alignment)
- [Executive Cardiovascular Dashboard](#executive-cardiovascular-dashboard)
- [Example Strategic Use Case](#example-strategic-use-case)
- [Strategic Benefits for Cardiovascular Services](#strategic-benefits-for-cardiovascular-services)
- [Recommended Discussion Topics for Cardiology Leadership](#recommended-discussion-topics-for-cardiology-leadership)
- [Vision](#vision)
- [About This Briefing](#about-this-briefing)

---

## Executive Summary

Cardiovascular disease remains one of the largest drivers of healthcare utilization, morbidity, mortality, and total cost of care. As healthcare organizations transition toward CMS Value-Based Care (VBC) models, cardiovascular programs are increasingly evaluated not only by procedural excellence but by their ability to improve outcomes across defined populations.

Cohort Studio™ provides a privacy-preserving Population Health Intelligence platform designed to help cardiovascular leaders identify high-risk populations, detect care gaps, measure organizational performance, and support coordinated interventions across primary care and specialty services.

Rather than functioning as another clinical registry, referral management system, or electronic medical record extension, Cohort Studio serves as an analytical intelligence layer that transforms:

- Clinical measurements
- Claims data
- Utilization patterns
- Quality indicators
- Chronic disease markers

into statistically validated population insights.

For cardiovascular leadership, the platform addresses strategic questions:

- Which populations carry the greatest cardiovascular risk?
- Where are evidence-supported care gaps occurring?
- Which interventions may reduce avoidable utilization?
- How can cardiology contribute measurable value under CMS reimbursement models?
- Where can specialty expertise improve longitudinal population outcomes?

The result is a shift from episodic cardiovascular intervention toward proactive cardiovascular population management.

---

## Strategic Context: Cardiology Under Value-Based Care

Historically, cardiovascular services have been organized around:

- Acute events
- Procedures
- Specialty referrals
- Hospital-based episodes

Value-Based Care changes the strategic objective. CMS increasingly rewards organizations for:

- Prevention
- Chronic disease control
- Reduced avoidable utilization
- Coordinated care
- Improved outcomes
- Responsible resource stewardship

The strategic question becomes:

> *"How can cardiovascular expertise improve outcomes across the entire attributed population?"*

rather than:

> *"How can cardiology manage individual episodes after disease develops?"*

Cohort Studio supports this population health transition.

---

## Cardiovascular Population Intelligence

### From Event-Based Care to Risk-Based Management

Many cardiovascular events occur after years of accumulating risk factors.

Cohort Studio helps organizations identify populations characterized by:

- Elevated cardiovascular risk
- Chronic disease burden
- Incomplete preventive management
- Medication management gaps
- Utilization patterns suggesting unmet need

Potential cardiovascular intelligence domains include:

- Atrial fibrillation
- Hypertension
- Coronary artery disease
- Heart failure risk
- Diabetes-associated cardiovascular risk
- Vascular disease overlap

The goal is not simply to identify more patients. The goal is to identify:

> Where targeted intervention is most likely to improve outcomes and Value-Based Care performance.

---

## Cardiology Applications

### 1. Atrial Fibrillation Population Management

Atrial fibrillation represents a major opportunity for coordinated cardiovascular population management.

Cohort Studio supports identification of populations requiring evaluation through:

- Atrial fibrillation risk assessment
- Stroke prevention opportunities
- Anticoagulation management gaps
- Cardiovascular risk stratification

The platform reflects how a real anticoagulation-measure population is actually defined: membership in the
measure's denominator already establishes AFib context, so there is no separate AFib flag to track or default.
Where a direct compliance signal is available (anticoagulated or not), that is the authoritative source for the
care-gap determination; where it is not, the platform falls back to inferring compliance from an anticoagulation
claim on record. Both paths are evaluated the same way, so a gap is never missed simply because the two data
sources describe compliance differently.

The platform supports organizational understanding of:

- Disease prevalence
- Management gaps
- Quality opportunities
- Potential avoidable complications

### 2. Cardiovascular Risk Stratification

Cardiovascular disease rarely exists in isolation. Patients often demonstrate overlapping risk domains:

- Diabetes
- Hypertension
- Vascular disease
- Obesity-related risk
- Chronic kidney disease indicators
- Prior cardiovascular events

Cohort Studio integrates these signals to identify populations requiring coordinated management. This supports collaboration among:

- Primary care
- Cardiology
- Endocrinology
- Vascular medicine
- Nephrology
- Care management teams

### 3. Heart Failure and Utilization Intelligence

Heart failure represents a major driver of:

- Emergency department utilization
- Inpatient admissions
- Readmissions
- Total cost of care

Cohort Studio can support population-level understanding of:

- High-risk cardiovascular populations
- Utilization patterns
- Chronic disease management opportunities
- Care coordination priorities

This enables movement from:

> *"Treating the hospitalization"*

toward:

> *"Preventing avoidable deterioration."*

### 4. Preventive Cardiovascular Care

The platform supports identification of evidence-supported preventive opportunities, including:

- Uncontrolled hypertension
- Cardiovascular risk factor gaps
- Medication management opportunities
- Incomplete monitoring
- Preventive care opportunities

These insights support primary care partnerships and quality improvement programs.

### 5. Stroke and Bleeding Risk Factor Intelligence

Anticoagulation decisions balance stroke prevention against bleeding risk, and Cohort Studio ingests the clinical
detail both sides of that balance depend on:

- Prior stroke or TIA
- Heart failure history
- Vascular disease history (prior MI, PAD, or aortic plaque)
- Elevated bleeding risk

These enrich the patient's clinical picture wherever it's reviewed, and are included in referral packets — so a
receiving specialist sees the stroke-versus-bleeding-risk context already gathered, not just an anticoagulation
order without its clinical rationale attached.

---

## Cardiology as a Population Health Partner

### Extending Cardiovascular Expertise Beyond the Referral Encounter

Under CMS Value-Based Care, primary care remains responsible for longitudinal population management. Cardiology contributes specialized expertise where it improves:

- Outcomes
- Quality metrics
- Disease control
- Resource utilization

Cohort Studio strengthens this relationship with a structured referral network, not an informal handoff:

- Referral targets are **suggested from the patient's own comorbid drivers**, routing toward the specialty that matches the clinical signal found
- Referrals are **attributed by TIN and TIN-NPI**, mirroring how MIPS actually partitions care between groups and providers
- A referral packet carries risk tier, care-gap flags, relevant cost detail, and clinical risk factors — structured detail a receiving team can act on immediately

The role of cardiology expands from:

> *"Managing referred cardiovascular disease"*

to:

> *"Helping the organization improve cardiovascular health outcomes."*

---

## Cross-Specialty Cardiovascular Intelligence

Cardiovascular disease intersects with multiple clinical domains. Cohort Studio identifies overlapping populations such as:

### Cardiology + Endocrinology

- Diabetes with cardiovascular risk
- Poor glycemic control
- Cardiovascular prevention opportunities

### Cardiology + Vascular Medicine

- Peripheral arterial disease
- Atherosclerotic disease burden
- Systemic vascular risk

### Cardiology + Primary Care

- Hypertension management
- Preventive cardiovascular risk reduction
- Medication optimization

---

## Evidence-First Analytics

### Confidence Before Action

Healthcare analytics can generate misleading conclusions when small or unstable populations are interpreted incorrectly.

Cohort Studio applies an evidence gate before executive reporting. Each cohort evaluates:

- Sample size sufficiency, using Student's t-based confidence intervals that widen appropriately at small n
- Confidence intervals
- Uncertainty
- Variance drift against a baseline — fitted from real historical claims when available, illustrative otherwise, with the source always disclosed
- Bayesian evidence estimates
- Statistical drift

A dedicated **small-cohort mode** extends this to smaller cardiology populations: rather than excluding a cohort that falls short of the standard threshold, it surfaces the finding with a Wilson interval and empirical-Bayes stabilization toward a broader reference rate — honestly wide, but visible instead of silently dropped.

Leadership receives validated populations, measurable opportunities, and reliable organizational intelligence — rather than unverified trends.

---

## Privacy-Preserving Architecture

Cohort Studio separates clinical operations from executive analytics.

### Clinical Layer

Supports:

- Patient care
- Provider workflows
- Care coordination
- Clinical decision-making

### Analytical Layer

Provides:

- Cardiovascular prevalence
- Quality measures
- Utilization trends
- Cost analysis
- Population risk estimates

Executive reporting excludes:

- Patient names
- Medical record numbers
- Addresses
- Direct identifiers

The platform is built to accept real patient-level claims extracts (keyed by MBI) and clinical risk-factor data (keyed by a facility encounter/financial number, resolved through a crosswalk) — not only the synthetic demonstration set. Both identifier types are hashed one-way at the moment of ingestion and never retained in the raw.

The organization gains intelligence without unnecessary exposure of Protected Health Information.

---

## CMS Value-Based Care Alignment

Cohort Studio supports cardiovascular service line objectives across several domains.

### Quality Performance

Potential measures include:

- Cardiovascular risk management
- Hypertension control
- Anticoagulation opportunities
- Preventive interventions
- Chronic disease management

### Cost Stewardship

Analytics support understanding of:

- Emergency department utilization
- Inpatient admissions
- Readmission patterns
- Total cost of care
- Observed versus expected expenditures

### Population Performance

Leadership can evaluate:

- Cardiovascular disease burden
- Risk distribution
- Intervention opportunities
- Longitudinal improvement

---

## Executive Cardiovascular Dashboard

A cardiovascular service line dashboard could provide:

### Population Overview

- Cardiovascular disease prevalence
- Atrial fibrillation burden
- High-risk populations
- Chronic disease overlap

### Quality Opportunities

- Management gaps
- Preventive opportunities
- Medication optimization opportunities

### Operational Intelligence

- Utilization trends
- Population risk changes
- Care coordination opportunities

### Value-Based Care Metrics

- Cost trends
- Avoidable utilization
- Quality improvement impact
- Population outcomes

---

## Example Strategic Use Case

### Identifying Cardiovascular Risk Before Acute Events

**Traditional model**

- Patient develops symptoms
- Acute evaluation occurs
- Cardiovascular disease is recognized
- Specialty care begins

**Population Intelligence model**

- Cohort Studio identifies an elevated cardiovascular risk population
- Evidence validation confirms a statistically meaningful cohort
- Primary care and specialty teams coordinate intervention
- Quality improvement actions are implemented
- Outcomes and utilization are measured

The organization moves from reactive cardiovascular treatment toward proactive risk management.

---

## Strategic Benefits for Cardiovascular Services

Cohort Studio enables cardiovascular programs to:

- Identify cardiovascular risk earlier
- Strengthen primary care partnerships
- Improve chronic disease management
- Support CMS quality performance
- Reduce avoidable utilization
- Demonstrate organizational value
- Expand cardiology's role in population health strategy

---

## Recommended Discussion Topics for Cardiology Leadership

### Current State

- How is cardiovascular population risk currently measured?
- What populations remain unidentified?

### Quality Strategy

- Which cardiovascular care gaps represent the greatest opportunity?

### Care Coordination

- How can cardiology better support attributed populations?

### Value-Based Care

- Which cardiovascular interventions influence quality and total cost?

### Analytics Integration

- What existing clinical and claims data sources could support implementation?

---

## Vision

The future of cardiovascular medicine extends beyond treatment of individual cardiovascular events.

High-performing cardiovascular programs will increasingly serve as population health partners, helping organizations prevent disease progression, reduce avoidable utilization, and improve measurable outcomes.

Cohort Studio™ provides the analytical foundation for this transition by combining:

- Evidence-gated cohort intelligence
- Cross-specialty cardiovascular insight
- Privacy-preserving analytics
- CMS Value-Based Care alignment

Together, these capabilities allow cardiovascular services to move from episodic disease management toward proactive, evidence-driven cardiovascular population health.

---

## About This Briefing

This briefing describes Cohort Studio™ as a conceptual population health intelligence platform, prepared to support strategic discussion with cardiovascular services leadership. The analytical patterns described — evidence-gated cohort intelligence, four-state clinical inference, cross-specialty risk identification, and aggregate-only reporting — reflect the platform's architecture and design intent.

Cohort Studio is not a medical device and is not validated for clinical decision-making. Any organizational deployment would require independent clinical validation, data governance review, and appropriate regulatory and institutional oversight (including IRB review where applicable) prior to use with real patient data. Figures, thresholds, and code sets referenced in supporting materials are illustrative unless drawn from an organization's own validated data.

This document is intended for strategic and planning discussions and should not be relied upon as a compliance, coding, or clinical determination.

---

**Prepared for:** Director, Cardiovascular Services
**Platform:** Cohort Studio™
**Strategic Focus:** Facilitating Value-Based Care Through Population Health Intelligence
